Alliance Global Partners Initiates Coverage On IGC Pharma with Buy Rating, Announces Price Target of $3.5
Portfolio Pulse from Benzinga Newsdesk
Alliance Global Partners has initiated coverage on IGC Pharma with a Buy rating and set a price target of $3.5.
July 17, 2024 | 11:59 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Alliance Global Partners has initiated coverage on IGC Pharma with a Buy rating and set a price target of $3.5.
The initiation of coverage with a Buy rating and a specific price target of $3.5 by Alliance Global Partners is likely to positively impact IGC Pharma's stock price in the short term. Such analyst ratings often lead to increased investor confidence and buying activity.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100